The fund has national and international investors, mainly institutional and private, including a commitment from the management team itself. It is a diversified base, with no investor contributing mor...
After more than a decade of research, in 2024 Bioo brought to market a pioneering solution that integrates biotechnology and energy: a biological battery capable of generating electricity autonomously...
The Basque biotech company Oncomatryx Biopharma has successfully completed a capital increase of approximately €58 million, with the ultimate goal of evolving from a biotech company to an integrated...
With this operation, Aptadel Therapeutics begins a new stage of expansion to drive forward development of its pioneering treatment for Ewing’s sarcoma. The company is preparing a Series A funding ro...
Biotechnology company 53Biologics, specialized in the development and manufacturing of biologic drugs, has announced the closing of a strategic funding round led by European private equity firm Ren...
InceptionBio, Ysios’ fourth vehicle, will focus on identifying and building companies based on cutting-edge science, with a special emphasis on Spain. The fund will invest in technology transfer pro...
Mikrobiomik marks a new milestone in its development with the European approval of EUTEGRA (MBK‑01), the first microbiota-based biological therapy for the treatment of Clostridioides difficile infec...
Blackstone launched its dedicated BXLS platform in 2018 to invest across the life cycle of companies and products in the key life science sectors. With $15 billion in assets under management as of Q4 ...
PHEMS is a Horizon Europe project that has been building the foundations of the Paediatric Health Data Space (PHDS), a secure, federated and interoperable ecosystem designed to enable the sharing of p...
Founded in 2018 by Guido Magrin and Luca Iozzia, TeiaCare develops advanced monitoring solutions for residential healthcare facilities such as nursing homes, rehabilitation centres, and dementia care ...
The financing round was led by Jeito Capital, with participation from additional new investors Vida Ventures, BPI France, and EIFO (Export and Investment Fund of Denmark), as well as all existing inve...
Iteria Biopharma has announced the closing of a Series Seed financing round of €5 million, contributed by Inveready, Xesgalicia and the founding partners. With this capital injection, the biotechnol...